APR 12 - 13 2017 Opens: 6:00 AM PT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Molecular Diagnostics 2017
16 28 5619

Join LabRoots in bringing together the molecular diagnostics community. Attend webcasts with top experts and interact with speakers during the live Q&A sessions. Earn continuing education credits and network with peers. Enjoy the complementary conference from your desk with no need for travel, and explore the virtual exhibit hall to learn about the latest technologies and techniques for your lab.
 
The 2nd Annual Molecular Diagnostics Virtual Conference is the premiere venue for scientists, technologists, and professionals to discuss and present the newest advances in molecular diagnostics testing. Attend this online event at no charge.
 
Topics discussed in last year’s event included:

  • Regulations in Molecular Diagnostics Clinical Laboratory Testing
  • Inherited Genetic Disorders and Prenatal Applications in Modern Medicine
  • Next Generation Sequencing (NGS) in the Clinical Laboratory: Reality vs. Opportunity
  • Precision medicine in Oncology
  • Liquid Biospies: Applications in Molecular Diagnostics
  • Infectious Disease Screening, Diagnosis and Monitoring
  • Molecular Diagnostics Applications in Point of Care
  • Genomic Health


Call for Posters
Plan now to have your poster included in the international Molecular Diagnostics 2017 Virtual Event!
Learn More

Our virtual conference allows you to participate in a global setting with no travel or cost to you. You can participate in exactly those parts which you are interested in and be back at your desk or bench in an instant. Virtual events remove time and place restrictions and ensure that everyone who wants to participate can do so. This virtual conference also offers increased reach for the global diagnostics community with a high degree of interaction through live-streaming video and chat sessions.


Continuing Education
By participating in this virtual event and watching webcast presentations, you can earn Free Continuing Education (CE) and/or Continuing Medical Education (CME) credits. To earn educational credits, you must view an entire presentation. Following the presentation you must click on the educational credit link provided for that particular speaker and follow the required process. Once you have completed the process, you will receive a certificate for the educational credit.

Use #LRmoldx to follow the conversation
 


Speakers:

Show Resources
Agenda
All times are Pacific Time
  • APR 12, 2017 06:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Standards for Microbiome and Metagenomics: Supporting the Commercial Translation of Microbiome Science
    Speaker: Scott Jackson, PhD
  • APR 12, 2017 07:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentaion - Variant interpretation in Molecular Diagnostics: Challenges and Knowledge Gaps
    Speaker: Robert Nussbaum MD, FACP, FACMG
  • APR 12, 2017 09:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation - Assessing Risk in Cervical Cancer Screening Management: The Role of HPV Genotyping
    Speaker: Catherine Behrens, MD, PhD, FACOG
    Sponsored By: Roche Diagnostics
  • APR 12, 2017 10:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    The Essential Role of the Molecular Identification of Microorganisms in the Management of Chronic Infections
    Speaker: Randall Wolcott, MD
  • APR 12, 2017 12:00 PM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    PAMA: The First Reporting Period is Over. What Does This Legislation Mean for Laboratorie
    Speaker: Roger Klein MD, JD, FCAP
  • APR 13, 2017 06:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Title coming soon
    Speaker: John Martignetti, MD, PhD
  • APR 13, 2017 07:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Ultra-sensitive single-molecule array (Simoa) technology to revolutionize CNS biomarkers
    Speaker: Andreas Jeromin, PhD
  • APR 13, 2017 09:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation - Title coming soon
    Speaker: Christopher Mason, PhD
  • APR 13, 2017 10:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Why Variants Matter: NGS Bioinformatics Simplified for Oncology & Virology
    Sponsored By: Vela Diagnostics
    Condie Carmack, PhD
    Vice President of Precision Oncology, Vela Dx
    Ahmed Mahmoud, PhD
    Director of Scientific Support for Vela Diagnostics, Bi...
  • Microbiome Standards related to Diagnostics
  • APR 12, 2017 06:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Standards for Microbiome and Metagenomics: Supporting the Commercial Translation of Microbiome Science
    Speaker: Scott Jackson, PhD
  • APR 13, 2017 09:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation - Title coming soon
    Speaker: Christopher Mason, PhD
  • Diseases and Disorders
  • APR 12, 2017 07:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentaion - Variant interpretation in Molecular Diagnostics: Challenges and Knowledge Gaps
    Speaker: Robert Nussbaum MD, FACP, FACMG
  • APR 13, 2017 07:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Ultra-sensitive single-molecule array (Simoa) technology to revolutionize CNS biomarkers
    Speaker: Andreas Jeromin, PhD
  • APR 12, 2017 09:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation - Assessing Risk in Cervical Cancer Screening Management: The Role of HPV Genotyping
    Speaker: Catherine Behrens, MD, PhD, FACOG
    Sponsored By: Roche Diagnostics
  • APR 13, 2017 10:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Why Variants Matter: NGS Bioinformatics Simplified for Oncology & Virology
    Sponsored By: Vela Diagnostics
    Condie Carmack, PhD
    Vice President of Precision Oncology, Vela Dx
    Ahmed Mahmoud, PhD
    Director of Scientific Support for Vela Diagnostics, Bi...
  • Pursue Microbiome Testing as a Companion Diagnostic
  • APR 12, 2017 10:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    The Essential Role of the Molecular Identification of Microorganisms in the Management of Chronic Infections
    Speaker: Randall Wolcott, MD
  • Regulatory Landscape
  • APR 12, 2017 12:00 PM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    PAMA: The First Reporting Period is Over. What Does This Legislation Mean for Laboratorie
    Speaker: Roger Klein MD, JD, FCAP
  • Immunotherapy
  • APR 13, 2017 06:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Title coming soon
    Speaker: John Martignetti, MD, PhD
Posters

POSTER SUBMISSION GUIDELINES

Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer reviewed. Submission is free.

 

SUBMIT YOUR ABSTRACT

Enter the following information to this Submission Form:

  • Poster Title
  • Your Name
  • Your Institution
  • Your Email
  • Abstract describing the poster

 

All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

 

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster.  LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

 

Questions? Email Posters@LabRoots.com

LabRoots Policy

Speakers

  • Robert Nussbaum MD, FACP, FACMG
    Chief Medical Officer, Invitae
    Biography
      Dr. Nussbaum is currently the Chief Medical Officer of Invitae, a genetic information and diagnostic company. From 2006-2015, he was the Holly Smith Professor of Medicine at UCSF, Chief of the Division of Genomic Medicine, director of the Genomic Medicine Initiative at UCSF, and Medical Director of both the Cancer Risk Program at the Helen Diller Family Cancer Center and the UCSF Program in Cardiovascular Genetics, where he continues to see patients as a volunteer clinical faculty member. He came to UCSF in 2006 from the Division of Intramural Research of the National Human Genome Research Institute, NIH, where he served for 12 years as Chief of the Genetic Diseases Research and Inherited Disease Research Branches. Before his time at NIH, he was a faculty member in the Department of Genetics at the University of Pennsylvania and an Attending Physician at Children's Hospital of Philadelphia. He received his training in medicine in the Harvard-MIT Joint Program in Health Technology, his internal medicine training at Barnes Hospital/Washington University, and his genetics training at Baylor College of Medicine. He is board certified in internal medicine, clinical genetics and clinical molecular genetics. Dr. Nussbaum directed the original research that led to the discovery of mutations in -synuclein in hereditary Parkinson disease in the mid 1990's and studied its role in Parkinson disease for nearly 20 years. For his work on Parkinson disease, he was awarded the Klaus Joachim Zülch-Prize for Neurological Research and the Jay Van Andel Award for Outstanding Achievement in Parkinson's Disease Research. He also carried out positional cloning and characterization of the gene mutated in Lowe syndrome that led to accurate biochemical and molecular genetic testing, for which he has been recognized three times with awards from the Lowe Syndrome Association. He is the co-author of over 200 peer-reviewed publications on a broad range of topics in basic and applied human genetics and is co-author with Drs. Roderick M. McInnes and Huntington F. Willard of the popular textbook of human genetics, Thompson and Thompson's Genetics in Medicine. He has received numerous teaching awards from the University of Pennsylvania, the National Human Genome Research Institute and the University of California, San Francisco, and was awarded the Excellence in Education Award of the American Society of Human Genetics with his co-authors Drs. Willard and McInnes. Dr. Nussbaum is a Director and Treasurer of the American Board of Medical Genetics and Genomics and has served on the Board of Directors of the American College of Medical Genetics and Genomics and on the Board of the American Society of Human Genetics, where he also served as President. He was elected to the Institute of Medicine in 2004 and the American Academy of Arts and Sciences in 2015.
    • Christopher Mason, PhD
      Associate Professor, Weill Cornell Medicine Dept. of Physiology and Biophysics
      Biography
        Dr. Mason's laboratory builds and deploys biochemical and computational technologies to understand and engineer human and other genomes. He is Principal Investigator or co-Investigator on several NASA missions and projects. Some missions will discern the molecular basis of changes in the human body during long-term human space travel, including genetic, epigenetic, transcriptional, and metagenomic changes. One additional mission is optimizing a new method of space-based DNA nanopore sequencing, and his group is also creating other genetic technologies and algorithms that can measure nucleic acids in space. Notably, the nanopore-based sequencing methods he has pioneered with NASA/UCSF scientists will enable mid-mission, rapid pathogen diagnostics for astronauts, create new applications of sequencing for space exploration (exobiology), and to discover novel DNA/RNA base modifications.
      • Catherine Behrens, MD, PhD, FACOG
        Consultant Senior Director, Clinical Research
        Biography
          Catherine Behrens did her PhD research at University of California San Francisco and attended medical school at Stanford University. She completed a Residency in Obstetrics and Gynecology, also at Stanford. Dr. Behrens was in clinical practice for over 20 years and maintains board certification from the American College of Obstetricians and Gynecologists. Dr. Behrens returned to research in the women's health field, initially at Genomic Health and then serving as Senior Director for Clinical Research at Roche Molecular Diagnostics from 2009 until 2015. During her tenure at Roche, Dr. Behrens was the clinical lead for the ATHENA study and a number of additional registrational trials. She currently serves as a consultant in women's health care.
        • Condie Carmack, PhD
          Vice President of Precision Oncology, Vela Dx
          Biography
            Condie Carmack, Ph.D. received his Ph.D. from the University of Utah in Experimental Pathology and did postdocs in Philadelphia, PA and San Diego, CA. in mouse genetics and molecular biology. He is the author or or co-author of 23 peer-reviewed journal. He wrote the first paper on quantitative PCR and the second paper on multiplex PCR. He served on the Science Advisory Board of Life Technologies Inc. as an expert in clinical PCR. He was co-author on the first paper creating human monoclonal antibodies from immunodeficient mice. Mice serve as the foundation for creation of the current immune checkpoint blockade antibodies such as ipilimumab and nivolumab. He also served as General Manager of the Cancer Genetics Lab at Baylor College of Medicine before joining Vela Diagnostics
          • Joseph Carmical, PhD
            Assistant Professor, Virol & Micro:Petrosino, Baylor College of Medicine
          • Scott Jackson, PhD
            Group Leader - Complex Microbial Systems, NIST
            Biography
              Undergraduate: Chemistry at University of South Carolina 1991-1996 Gradate: Univ. of Maryland and Johns Hopkins Univ - Biochemistry and Molecular Genetics 1996-2003 2003-2014 - Food and Drug Administration (FDA) Center for Food Safety. Principal Investigator. Developed Molecular Genetic Tools for the Identification of Foodborne Pathogens 2014-Present: NIST Group Leader - Complex Microbial Systems Group. Oversee new program focusing on Microbial Metrology. Co-founder of the International Metagenomics and Microbiome Standards Alliance (IMMSA)
            • Andreas Jeromin, PhD
              Chief Medical Officer (consulting), Quanterix Corp
              Biography
                Andreas Jeromin, PhD, has more than 25 years of experience in CNS clinical diagnostics and companion diagnostics and co-authors more than 150 publications. He is the founder of Atlantic Biomarkers, Inc., and currently the consulting Chief Medical Officer to Quanterix Corp and member of several biomarker/CNS disorder consortia and working groups.
              • Roger Klein MD, JD, FCAP
                Principal at Roger D. Klein, MD JD Consulting, Cleveland Clinic, Chair, Professional Relations Committee, Association for Molecular Pathology (AMP); Medical Director, Molecular Oncology
                Biography
                  Roger D. Klein, M.D., J.D., serves as Medical Director of Molecular Oncologyo at Bloodcenter Of Wisconsin, Inc. Dr. Klein lead the development of BloodCenter of Wisconsin's Diagnostic Laboratories' newest initiative, which will focus on DNA- and RNA-based testing for evaluation of cancer patients. Dr. Klein comes to BloodCenter from H. Lee Moffitt Cancer Center where he served as Medical Director of Molecular Diagnostics and was an Assistant Professor in the Department of Oncologic Sciences, at the University of South Florida Medical School in Tampa, FL. Dr. Klein's academic and clinical efforts focus on the translation of molecular genetic knowledge into clinical diagnostic tests. In addition, Dr. Klein has an active research program involving the ethical, legal and social implications (ELSI) of the Human Genome Project, with particular emphasis on the areas of intellectual property and the regulation of in vitro diagnostics and clinical laboratories. Dr. Klein is a member of the CDC's Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group and a consultant to the FDA's Clinical and Molecular Genetics Advisory Panel. He also serves on the College of American Pathologists' Molecular Oncology Resource Committee, and the Association for Molecular Pathology's Professional Relations and CPT Coding Committees. He completed residency training in Laboratory Medicine, together with fellowships in Medical Microbiology and Molecular Genetics, at Yale University School of Medicine in New Haven, CT, followed by a fellowship in Molecular Genetic Pathology at Mayo Clinic in Rochester, MN. In addition, Dr. Klein earned a law degree from Yale Law School. He is board-certified in Clinical Pathology and Molecular Genetic Pathology. Dr. Klein earned his medical degree and completed an internship in Internal Medicine at Case Western Reserve University in Cleveland, OH.
                • Ahmed Mahmoud, PhD
                  Director of Scientific Support for Vela Diagnostics, Bioinformatics Applications scientist
                  Biography
                    Ahmed Mahmoud is an experienced scientist with both hands-on lab and bioinformatics experience with degrees in both molecular biology and bioinformatics. Ahmed is currently the Director of Scientific Support for Vela Diagnostics as well as a Bioinformatics Applications scientist. Ahmed's team handles all technical wet lab and informatics support for Vela Diagnostic's qPCR and NGS workflows, assisting with pipeline creation for various NGS workflows and robotic application writing for automated systems. He has experience developing qPCR and Automated NGS workflows as well as extensive experience in NGS data analysis using multiple sequencing platforms. He has held positions in various areas of the biotech industry with institutions such as GeneDX, Pfizer and Columbia University Medical Center. Ahmed is also an avid iOS developer, creating computer apps geared towards the science sector.
                  • John Martignetti, MD, PhD
                    Icahn School of Medicine at Mount Sinai Departments of Genetics and Genomic Sciences, Pediatrics, Obstetrics/Gynecology & Reproductive Sciences and Oncological Sciences
                    Biography
                      John A. Martignetti, MD, PhD, an expert in human genetics and genomic sciences at the Icahn School of Medicine at Mount Sinai, as the Network Director of the Laboratory for Translational Research at the WCHN Biomedical Research Institute. Under this collaboration, Dr. Martignetti's well-established bedside to bench cancer research methodology will be extended to patients at Danbury, Norwalk and New Milford hospitals leading to more personalized and successful therapeutic strategies. He will work closely with the oncology physicians and research scientists across WCHN to build on their nationally recognized efforts.
                    • Randall Wolcott, MD
                      Medical Director, Southwest Regional Wound Care Center
                      Biography
                        Dr. Randall Wolcott is the founder of the Southwest Regional Wound Care Center in Lubbock, TX. The Wound Care Center specializes in biofilm-based wound care. The Wound Care Center offers state of the art technology with molecular diagnostics and state of the art alternative medicine including customized topical wound gels. He is passionate about healing wounds.
                      Sponsored By

                      For information on becoming a sponsor or exhibitor, please click here.


                      Continuing Education (CME/CE/CEU) Credits

                      The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                      Committee

                      To download the Program Committee brochure here.


                      • Bryan Cobb, PhD, FACMG

                        Dr. Cobb is the acting Director for Clinical Molecular Diagnostics at Roche Diagnostics Corporation where he serves in a scientific advisory role supporting the laboratory scientific community. He obtained his Ph.D. in Medical Genetics at the University of Alabama at Birmingham ...

                        See more See less
                      • Shawn Baker, PhD

                        Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench ...

                        See more See less
                      • Jason Alter, PhD

                        Dr. Jason Alter is the Director of Clinical Genomic Affairs for GenomeDx Biosciences. He and his team specialize in the integration of advanced genomic testing with clinical practice. Jason has extensive experience in the field of prostate cancer prognostic assay development and ...

                        See more See less
                      • Martin Latterich, PhD

                        The discovery of proteinaceous disease biomarkers and their clinical validation is critically important for the enablement of molecular diagnostics and ultimately, precision medicine. In spite of the importance of biomarkers, research done in the last two decades has yielded ...

                        See more See less
                      • Judd Moul, MD, FACS

                        Judd W. Moul is James H. Semans, MD Professor of Surgery, Division of Urologic Surgery, and Director of the Duke Prostate Center, Duke Cancer Institute at Duke University Medical Center. Prior to joining Duke, he was Professor of Surgery at the Uniformed Services University of ...

                        See more See less
                      • Emily Hollister, PhD

                        Dr. Hollister is a microbial ecologist and bioinformaticist. She is interested in quantifying and characterizing microbial communities from a wide variety of environments, including the human body. Utilizing high throughput, next-generation DNA and RNA sequence approaches, her ...

                        See more See less
                      Help

                      General LabRoots Questions

                      For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                      Contact us

                      Virtual Events and Webinars

                      Supported Configurations

                      • Operating System Internet Explorer Firefox Chrome Safari
                        Vista IE8+ FF10+ Chrome15+
                        Windows 7 IE8+ FF10+ Chrome15+
                        Windows 8 IE10 FF10+ Chrome15+
                        Mac OS X   FF10+ Chrome15+ Safari5.1+
                      • Cookie settings: session cookies enabled
                      • Browser configuration must have JavaScript enabled
                      • Adobe Flash player 10.2 or later

                      To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                      Internet Connection

                      • A minimum of 100Kbps is recommended for audio-only events
                      • A minimum of 300Kbps is recommended for speaker on-video events

                      Computer Equipment

                      • Screen Resolution: Minimum 1024x768
                      • Video Card: 65,000 colors minimum
                      • Sound card and speakers (or headphones) for hearing webcast in full format
                      • Audio Card: 16-bit minimum
                      • RAM: 512MB of free RAM

                      Firewall Protocol

                      • HTTP on port 80 or HTTPS on port 443
                      • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                      • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                      Work-At-Home Attendees

                      • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                      For A Seamless Experience

                      When using a mobile device, FREE Mobile Apps are available:

                      - For viewing Webinars:

                      - For viewing Virtual Events

                      Attendee Guide

                      • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                      Virtual Event and Webinar Support:

                      Continuing Education (CME/CE) Support

                      Loading Comments...